Skip to search formSkip to main contentSkip to account menu

Lopid

Known as: Lipur, Lopid R 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • 2017
  • Corpus ID: 44822173
DESCRIPTION LOPID (gemfibrozil tablets, USP) is a lipid regulating agent. It is available as tablets for oral administration… 
1999
1999
Renal and hepatic subacute toxicity induced by the antihyperlipidaemic drugs: Bezalip ‐ Pravastatin and Lopid was investigated in… 
1995
1995
Hyperlipidemia is a common side-effect of oral retinoid treatment, which sometimes interferes with long-term therapy. To evaluate… 
1991
1991
If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… 
1990
1990
In 25 patients with primary dyslipoproteinemias and severe premature atherosclerosis, during an average combined Lopid-Mevacor… 
1989
1989
1982
1982
This report describes the results of long-term treatment for blood lipid regulation with a new drug, gemfibrozil (Lopid®). During…